DYSBACTERIOSIS IN PREGNANT WOMEN WITH COVID - 19

Fayzullayeva Zamira Rahmatovna; Yahyayeva Mavjuda Haydarovna; Egamberdiyeva Alina Rahimjanovna; Mustafoqulov Jonibek Rustamvich

dc.contributor.author	Fayzullayeva Zamira Rahmatovna
dc.contributor.author	Yahyayeva Mavjuda Haydarovna
dc.contributor.author	Egamberdiyeva Alina Rahimjanovna
dc.contributor.author	Mustafoqulov Jonibek Rustamvich
dc.date.accessioned	2023-04-04T08:58:33Z
dc.date.available	2023-04-04T08:58:33Z
dc.date.issued	2023-03-10
dc.identifier.issn	2181-3868
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/6918
dc.description.abstract	The COVID-19 pandemic, which was announced by WHO in March 2020, has made major adjustments to the life of modern society. Pregnancy during a period of increased danger, if there is a possibility in the risk group. In this case, the likelihood of a more severe course of infection with the advent of the population is increased due to the occurrence of diseases of the immune system and concomitant diseases. The placenta is an endocrine organ that produces a number of protein and steroid hormones in the blood, such as human chorionic gonadotropin, placental lactogenic hormone, progesterone, and estrogens. Metabolic changes during pregnancy increase the production of placental hormones in the second half of pregnancy. The gut microbiota plays an important role in maintaining the basic functions in the human body: metabolic, protective and trophic. It is a controlling factor in the processes of digestion.	en_US
dc.language.iso	en	en_US
dc.publisher	Innovation: The journal of social sciences and researches	en_US
dc.subject	intestinal microbiocenosis, microbiota, pregnancy and health (BZ), intestinal diseases (BK)	en_US
dc.title	DYSBACTERIOSIS IN PREGNANT WOMEN WITH COVID - 19	en_US
dc.type	Article	en_US